Biblio

Author Title [ Type

] Year

Filters: Author is Zhang, Tongcun [Clear All Filters]

Journal Article

Li X, Gong N, Tian F, Zhang S, Zhang Y, Wang Y, Qing G, Wang Y, Li F, Xu Y, et al. Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel. Nat Biomed Eng. 2023.

Liu Q, Xing S, Liu Y, Zhang Z, Lv L, Cui Z, Li Z, Ma W, Zhang T. A Perfused Microfluidic System to Study the Differentiation of Neural Stem Cells in vitro. Cells Tissues Organs. 2018:1-8.

Zhang S, Zhou X, Zhang S, Wang N, Zhang T, Zhang D, Ao Q, Cao Y, Huang L. EBV-associated lymphoproliferative disease post-CAR-T cell therapy. Front Med. 2024.

Su K, Lin N, Xie S, Han Y, Yang Z, Zhang H, He H, Zhou S, Ma W, Zhang T, et al. DNMT3A inhibits E2F1-induced arterial marker expression and impairs angiogenesis in human umbilical artery endothelial cells. Acta Biochim Biophys Sin (Shanghai). 2020.

Chen L, Ren A, Zhao Y, Chen H, Wu Q, Zheng M, Zhang Z, Zhang T, Zhong W, Lin J, et al. Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL. J Hematol Oncol. 2023;16(1):113.

Cao Y, Yi X, Wang N, Wang GX, Huang L, Hong Z, Meng L, Zhou X, Wang J, Hao X, et al. CD19/CD22 CAR T cell Cocktail Therapy Following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas: Combined CAR T Cell Therapy and Transplantation. Transplant Cell Ther. 2021.